Clinical Trials

Urothelial Cancer

NCT03474107 2026-01-09

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

608 enrolled 22 charts 1 FDA

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT04527991 2025-08-03

TROPiCS-04

712 enrolled

Locally Advanced or Metastatic Unresectable Urothelial Cancer

NCT01095003 2022-04-28

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

770 enrolled 13 charts

Breast Neoplasms

NCT00545766 2021-12-16

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

41 enrolled 11 charts

Prostatic Neoplasms

NCT02256436 2021-09-20

MK-3475-045

542 enrolled 31 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT02057913 2020-07-23

VinCaP

22 enrolled

Penile Neoplasms

NCT02665039 2019-10-08

VINGEM

62 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT01091168 2019-09-16

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

594 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02302807 2019-08-01

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

931 enrolled 21 charts

Urinary Bladder Neoplasms

NCT01953003 2019-05-02

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

112 enrolled 11 charts

Breast Neoplasms

NCT01844947 2019-04-26

VINSOR

22 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT01529411 2019-04-04

MAJA

86 enrolled

Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

NCT02347332 2019-03-05

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

459 enrolled 13 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT02845050 2018-02-13

JaNEO

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Phase 2 Terminated

18 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00450515 2016-12-06

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male

NCT00362830 2016-09-19

A Study of the Alternative Administration of Ixabepilone and Vinflunine

60 enrolled

Neoplasms

NCT00388557 2016-09-19

Effect of Ketoconazole on the Pharmacokinetics of Vinflunine

35 enrolled

Neoplasms

NCT01599013 2015-12-08

JASINT1

69 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urogenital Neoplasms, Urologic Neoplasms, Renal Insufficiency

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Phase 2/3 Completed

34 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT00534807 2015-09-01

A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Phase 1 Withdrawn

Neoplasms

NCT01830231 2014-01-28

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Phase 2/3 Unknown

372 enrolled

Neoplasm Metastasis

NCT00284180 2013-08-09

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

32 enrolled 6 charts

Breast Neoplasms

NCT00284154 2013-03-13

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

51 enrolled 10 charts

Thoracic

Lung Neoplasms, Recurrence, Carcinoma, Small Cell

NCT01265940 2012-10-10

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Phase 1/2 Completed

5 enrolled

Urinary Bladder Neoplasms

NCT00320073 2012-05-16

Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors

41 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00251446 2012-05-11

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00101608 2010-03-02

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

150 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Kidney Neoplasms, Ureteral Neoplasms

NCT00359476 2010-03-02

A Study of Vinflunine in Patients With Gastric Cancer

Phase 2/3 Terminated

55 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00315237 2010-01-07

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

364 enrolled